Zobrazeno 1 - 10
of 36
pro vyhledávání: '"A G SOLODOVNIKOV"'
Autor:
Zh E Belaya, L Ya Rozhinskaya, N V Dragunova, A G Solodovnikov, A V Ilyin, G A Melnichenko, I I Dedov, L K Dzeranova
Publikováno v:
Остеопороз и остеопатии, Vol 15, Iss 2, Pp 3-8 (2012)
Purpose. Endogenous Cushing’s syndrome (CS), usually affecting young and otherwise healthy patients, is a good model to validate the effects of supraphysiological levels of glucocorticoids in humans. This study evaluates circulating levels of extra
Externí odkaz:
https://doaj.org/article/2c2e389920fd43b2a83e5fe89e9f81fd
Autor:
O M Lesnyak, N N Krokhina, O E Alferova, A G Solodovnikov, A G Zakroeva, O F Ryahitsevu, E. M. Avdeeva
Publikováno v:
Научно-практическая ревматология, Vol 46, Iss 6, Pp 27-32 (2008)
Objective. To study the prevalence of osteoarthritis and joint complaints among urban and rural inhabitants Material and methods. Simultaneous cross-sectional epidemiological study among inhabitants of Revda town and nine rural settlements of Nevijan
Externí odkaz:
https://doaj.org/article/eb0dbbdf28064e51b9f606d5de0bb516
Publikováno v:
Научно-практическая ревматология, Vol 45, Iss 3, Pp 46-53 (2007)
Externí odkaz:
https://doaj.org/article/1c7c3c21090949b3af1b5e0fa4f53a64
Autor:
A A Popov, N. V. Ismozerova, N. V. Tagiltseva, O Y Stryukova, A. V. Akimova, Af I Fominyh, A G Solodovnikov
Publikováno v:
Научно-практическая ревматология, Vol 45, Iss 2, Pp 8-13 (2007)
Objective. To study prevalence of knee joints osteoarthritis (OA) in menopausal women and its influence on menopausal syndrome severity and quality of life of pts. Material and methods. A random sample (673 pts) from the general population of pts (67
Externí odkaz:
https://doaj.org/article/7147fc9f3083486189728bfaa3c60c29
Autor:
A G Solodovnikov
Publikováno v:
Остеопороз и остеопатии, Vol 19, Iss 1, Pp 20-20 (2016)
Externí odkaz:
https://doaj.org/article/8fcceb27d2314cf08762aa407f2cf1e2
Autor:
A G SOLODOVNIKOV, O M LESNYaK, K Yu BELOVA, O V DOBROVOL'SKAYa, Yu A VARAVKO, G Sh GOLUBEV, V A GREBENShchIKOV, OB ERShOVA, E G ZOTKIN, S N IVANOV, A Yu KOChISh, L V MEN'ShIKOVA, RZ NURLYGAYaNOV, N V TOROPTsOVA, K P USENKO
Publikováno v:
Остеопороз и остеопатии, Vol 19, Iss 2, Pp 15-15 (2016)
Медико-социальную и экономическую значимость остеопороза определяют его неуклонно нарастающая распространенность, а также затраты на
Externí odkaz:
https://doaj.org/article/30edd56b586349c9851bb45fdcd171dc
Autor:
E Yu KADOChNIKOVA, A A VLASOV, L I ALEKSEEVA, I G DYDYKINA, O B ERShOVA, E M ZAYTsEVA, T A KOROTKOVA, T A POPOVA, M L SUKhAREVA, E A TASKINA, E P ShARAPOVA, A G SOLODOVNIKOV, O M LESNYaK
Publikováno v:
Остеопороз и остеопатии, Vol 19, Iss 2, Pp 107-107 (2016)
Динамическая электронейростимуляция (ДЭНС) - вид ЧЭНС, основанный на применении слабых (200-400мкА), низкочастотных (10-200 Гц) импульсных токо
Externí odkaz:
https://doaj.org/article/e7b401a488c3426bb09e59e3357ab4f4
Autor:
G. A. Tsaur, T. V. Nasedkina, A. M. Popov, O. V. Kalennik, A. G. Solodovnikov, T. O. Riger, Yu. A. Yakovleva, A. S. Ivanova, A. E. Druy, O. M. Plekhanova, E. V. Shorikov, L. I. Saveliev, L. G. Fechina
Publikováno v:
Онкогематология, Vol 0, Iss 2, Pp 46-54 (2022)
Early therapy response is one of the major prognostic factors influencing an outcome of acute lymphoblastic leukemia (ALL). The purpose of the given work was to define a time point (TP) of fusion gene transcript (FGt) monitoring by reverse-transcript
Externí odkaz:
https://doaj.org/article/bccdae5e6fb84086b30c2fa0980c4bf2
Autor:
Tatiana A. Grebennikova, Zhanna E. Belaya, Alexey G. Nikitin, Olga I. Brovkina, Alexander G. Solodovnikov, Larisa K. Dzeranova, Galina A. Melnichenko
Publikováno v:
Ожирение и метаболизм, Vol 14, Iss 3, Pp 32-37 (2017)
Backgraund. MiсroRNA are small regulatory factors that regulate gene expression by post-transcriptional regulation of mRNA, playing an important role in numerous cellular processes including organogenesis, apoptosis, cell proliferation and different
Externí odkaz:
https://doaj.org/article/361a5627a2234c549dfda619be3c9ade
Publikováno v:
The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. Regulatory Research and Medicine Evaluation. 12:300-309
The manufacture of different medicinal products in shared facilities creates a risk of cross-contamination. One of the approaches to select the limits for possible contaminants is based on calculating the permitted daily exposure (PDE), i.e. the dose